Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan Agreements

Los Angeles JOLLA, Calif. , Aug. 31, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical business centered on the breakthrough and growth of revolutionary medications focusing on microRNAs, today announced that pursuant to an amendment of its term loan contract with Oxford LLC, the organization is eligible for up to yet another seven months of great interest just re re payments if your Company pays down ten dollars million in loan principal before April 30, 2021 (the "Principal Paydown Event") utilizing arises from the purchase of materials to, and prospective milestones received from, Sanofi as described below. להמשיך לקרוא

יצירת קשר

שם *
אימייל *
טלפון
הודעה
s-jersey_c-407.html">Dion Lewis Womens Jersey